OncoCyte Corp Stock Forecast - Naive Prediction
| OCX Stock | USD 2.93 0.14 4.56% |
The Naive Prediction forecasted value of OncoCyte Corp on the next trading day is expected to be 2.99 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.42. OncoCyte Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast OncoCyte Corp stock prices and determine the direction of OncoCyte Corp's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of OncoCyte Corp's historical fundamentals, such as revenue growth or operating cash flow patterns. Although OncoCyte Corp's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of OncoCyte Corp's systematic risk associated with finding meaningful patterns of OncoCyte Corp fundamentals over time.
Check out Historical Fundamental Analysis of OncoCyte Corp to cross-verify your projections. OncoCyte |
Most investors in OncoCyte Corp cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the OncoCyte Corp's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets OncoCyte Corp's price structures and extracts relationships that further increase the generated results' accuracy.
A naive forecasting model for OncoCyte Corp is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of OncoCyte Corp value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period. OncoCyte Corp Naive Prediction Price Forecast For the 20th of May
Given 90 days horizon, the Naive Prediction forecasted value of OncoCyte Corp on the next trading day is expected to be 2.99 with a mean absolute deviation of 0.06, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.42.Please note that although there have been many attempts to predict OncoCyte Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that OncoCyte Corp's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
OncoCyte Corp Stock Forecast Pattern
| Backtest OncoCyte Corp | OncoCyte Corp Price Prediction | Buy or Sell Advice |
OncoCyte Corp Forecasted Value
In the context of forecasting OncoCyte Corp's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. OncoCyte Corp's downside and upside margins for the forecasting period are 0.23 and 5.76, respectively. We have considered OncoCyte Corp's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of OncoCyte Corp stock data series using in forecasting. Note that when a statistical model is used to represent OncoCyte Corp stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.8416 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.056 |
| MAPE | Mean absolute percentage error | 0.02 |
| SAE | Sum of the absolute errors | 3.4151 |
Predictive Modules for OncoCyte Corp
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as OncoCyte Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of OncoCyte Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for OncoCyte Corp
For every potential investor in OncoCyte, whether a beginner or expert, OncoCyte Corp's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. OncoCyte Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in OncoCyte. Basic forecasting techniques help filter out the noise by identifying OncoCyte Corp's price trends.OncoCyte Corp Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OncoCyte Corp stock to make a market-neutral strategy. Peer analysis of OncoCyte Corp could also be used in its relative valuation, which is a method of valuing OncoCyte Corp by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
OncoCyte Corp Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of OncoCyte Corp's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of OncoCyte Corp's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
OncoCyte Corp Market Strength Events
Market strength indicators help investors to evaluate how OncoCyte Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading OncoCyte Corp shares will generate the highest return on investment. By undertsting and applying OncoCyte Corp stock market strength indicators, traders can identify OncoCyte Corp entry and exit signals to maximize returns.
OncoCyte Corp Risk Indicators
The analysis of OncoCyte Corp's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in OncoCyte Corp's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncocyte stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.86 | |||
| Semi Deviation | 2.58 | |||
| Standard Deviation | 2.84 | |||
| Variance | 8.05 | |||
| Downside Variance | 9.39 | |||
| Semi Variance | 6.66 | |||
| Expected Short fall | (2.28) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether OncoCyte Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OncoCyte Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncocyte Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncocyte Corp Stock:Check out Historical Fundamental Analysis of OncoCyte Corp to cross-verify your projections. For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.Note that the OncoCyte Corp information on this page should be used as a complementary analysis to other OncoCyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for OncoCyte Stock analysis
When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is OncoCyte Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OncoCyte Corp. If investors know OncoCyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OncoCyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.37) | Revenue Per Share 0.196 | Quarterly Revenue Growth 0.146 | Return On Assets (0.16) | Return On Equity (0.76) |
The market value of OncoCyte Corp is measured differently than its book value, which is the value of OncoCyte that is recorded on the company's balance sheet. Investors also form their own opinion of OncoCyte Corp's value that differs from its market value or its book value, called intrinsic value, which is OncoCyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OncoCyte Corp's market value can be influenced by many factors that don't directly affect OncoCyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OncoCyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if OncoCyte Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OncoCyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.